NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Adherence Connection for Counseling, Education, and Support (ACCESS) II

CompletedNA

Sponsor: NYU Langone Health

Conditions: HIV Infections

Interventions: ACCESS II mHealth Intervention, ACCESS II control condition

Countries: United States

The primary objective of the proposed clinical trial, Adherence Connection for Counseling, Education, and Support (ACCESS)-II, is to test the efficacy of ACCESS-II on antiretroviral treatment (ART) adherence and HIV-viral load in Black and Hispanic HIV-infected (HIV+) adolescents and young adults (AYA), ages 18-29 years (N=120) using a longitudinal (12 and 24 week outcomes), two-group, randomized control trial (RCT). Participants in the intervention condition will use videoconferencing to connect synchronously with trained HIV+ peer health coaches who will deliver eight weekly, 60-minute cognitive behavioral/motivational sessions for improved ART adherence. Participants in the control will connect asynchronously to a web-based HIV ART adherence education condition.

Eligibility overview

Sex: ALL

Age: 18 Years to 29 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion criteria for participation in this study are:

* HIV seropositive status (perinatally and behaviorally infected youth)
* Ages 18-29 years
* English speaking
* Currently being prescribed an antiretroviral treatment regimen
* Evidence of virologic failure or (detectable quantitative HIV serum viral load\>200 copies/ml)
* No neuro-cognitive deficits which would impede participation in videoconferencing sessions or completion of study measures

Locations (1)

The Bronx, New York, United States